Tienes más de 18 años y quieres participar en un estudio de Fase IIb sobre una nueva vacuna frente el COVID-19?

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
HIPRA, COVID-19, vacunas, Pfizer-BioNTech, investigación

El promotor HIPRA está buscando personas voluntarias mayores de 18 años que hayan recibido la vacuna Comirnaty de Pfizer-BioNTech contra la COVID-19 como mínimo hace 6 meses, para estudiar una nuev...

Pneumonia causes 2.5 million deaths around the world each year

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
respiratory infections, pneumonia, diagnosis, vaccine

nterview with Dr Catia Cilloniz, a microbiologist and doctor of medicine at the applied research group on respiratory infections and critical illness at Hospital Clínic de Barcelona, and leader of th...

Scientists study the physiopathological mechanisms that intervene in the development of chronic thromboembolic pulmonary hypertension

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
IDIBAPS, Pulmonary embolism, CTEPH, Pulmonar hypertension, Research

The study, published by the journal Scientific Reports, presents the development of an innovative model of endothelial pathology of CTEPH in vitro, based on cells obtained from pulmonary endarterectom...

DHX15 suppression, as a possible therapeutic target against metastasis

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
metastasis, Cardiovascular disease, Research, IDIBAPS

The study, led by IDIBAPS researchers, also demonstrates the role of the molecule in vascular function.

Daily consumption of walnuts reduces 'bad' cholesterol and improves the quality of low-density lipoprotein (LDL)

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
cholesterol, LDL, walnuts, diet, healthy ageing, Cardiovascular disease, High blood pressure

The Hospital Clínic-IDIBAPS is carrying out a trial to explore the effects of a diet enriched with walnuts for two years on healthy ageing in individuals over 63 years of age. It shows a reduction in...

Identified a new mechanism that promotes angiogenesis in chronic liver disease

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
chronic liver disease, angiogenesis, Research

IDIBAPS researchers describe, for the first time, the role of ductular reaction in the formation of new blood vessels.

BACE2 inhibition aggravates the metabolic consequences of a high-fat diet in mice

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
diabetes, Alzheimer’s disease, obesogenic high-fat diet, proteins

Type 2 diabetes (DM2) and obesity are closely linked. A study conducted by researchers from CIBERDEM and IDIBAPS has demonstrated that the absence of the protease BACE2 (β-site APP-cleaving enzyme 2)...

Researchers from the IIBB-CSIC-IDIBAPS participate in a study that shows the interaction of the receptor for cannabinoids with the BiP protein in terminals of inhibitory neurons, modulating anxiety

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
cannabis, brain, Research, Anxiety

The findings open a new conceptual framework to understand the striking context-dependent pharmacological actions of cannabis in the brain.

Simplification of antiretroviral treatment will improve the quality of life of HIV patients

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Research, Treatment, HIV/AIDS, Infectious Diseases

A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy. It does not cause resistance or have any side effe...

Día Europeo contra la Depresión: La depresión resistente al tratamiento suma cada año 44.000 nuevos afectados en España

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Psicología, Psiquiatría, Depresión, Investigación, Trastornos bipolares

Un estudio del CIBERSAM con participación del Clínic-IDIBAPS concluye que la Depresión Resistente al Tratamiento tiene una incidencia media en España de 0,93 casos por cada 1000 personas.

It has been shown that COVID-19 can damage the placenta in pregnant women

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
pregnant, placenta, Covid19, Coronavirus

Researchers from the CLÍNIC-IDIBAPS, the Hospital Universitari Vall d’Hebron and the Parc Taulí de Sabadell have shown the damage caused by the SARS-CoV2 virus to the placentas of around 200 pregn...

Dr. Jacobo Sellarés: 'The best ICU treatment is the one that keeps you out of the ICU'

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Pulmonology and Respiratory Allergy Service, ICU, Pneumology, COVID, coronavirus

Interview with Dr. Jacobo Sellarés, Head of the Interstitial Lung Disease Working Group. Pulmonology and Respiratory Allergy Service at the Hospital Clínic de Barcelona.